FacultyFaculty/Author Profile
Benjamin C. Hsing

Benjamin C. Hsing

Baker & Hostetler LLP

New York, NY, USA


Ben Hsing is a partner at BakerHostetler.  Ben is a patent litigator possessing experience with a range of technologies and focuses his practice on the enforcement of patent rights in the life sciences industry, with a concentration in Hatch-Waxman-based litigations. Ben is an accomplished trial lawyer, having tried numerous high-profile cases on behalf of major pharmaceutical and technology companies. As a former patent examiner, Ben is well-versed in USPTO proceedings and assists clients in post grant and contested patent office proceedings. He is also experienced in conducting intellectual property due diligence investigations in connection with acquisitions and licensing deals.

Ben is a graduate of Columbia University and received his J.D. from the George Washington University Law School.

Benjamin C. Hsing is associated with the following items:
CHB Chapters  CHB Chapters 35 U.S.C. §101: The Complete Guideline Breakdown of Alice, Myriad and Mayo - Patent Eligibility, Prior Art and Obviousness 2017: Current Trends in Sections 101, 102, and 103, Thursday, June 15, 2017
Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review - Developments in Pharmaceutical and Biotech Patent Law 2017, Wednesday, November 01, 2017
Web Segment  Web Segment 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo - Patent Eligibility, Prior Art and Obviousness 2017: Current Trends in Sections 101, 102, and 103, Monday, June 19, 2017
Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
MP3 Audio  MP3 Audio 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo - 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo, Monday, June 19, 2017
Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review - Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review, Thursday, November 02, 2017
Transcripts  Transcripts 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo - 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo, Monday, June 19, 2017
Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review - Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review, Thursday, November 02, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo - 35 USC 101: The Complete Guideline Breakdown of Alice, Myriad and Mayo, Monday, June 19, 2017
Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review - Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review, Thursday, November 02, 2017
On-Demand Web Programs  On-Demand Web Programs Patent Eligibility, Prior Art and Obviousness 2017: Current Trends in Sections 101, 102, and 103, Monday, June 26, 2017, San Francisco, CA
Developments in Pharmaceutical and Biotech Patent Law 2017, Monday, November 06, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.